Imran et al., 2018 - Google Patents
Emerging applications of porphyrins and metalloporphyrins in biomedicine and diagnostic magnetic resonance imagingImran et al., 2018
View HTML- Document ID
- 6825231244343595870
- Author
- Imran M
- Ramzan M
- Qureshi A
- Khan M
- Tariq M
- Publication year
- Publication venue
- Biosensors
External Links
Snippet
In recent years, scientific advancements have constantly increased at a significant rate in the field of biomedical science. Keeping this in view, the application of porphyrins and metalloporphyrins in the field of biomedical science is gaining substantial importance …
- 150000004032 porphyrins 0 title abstract description 78
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Imran et al. | Emerging applications of porphyrins and metalloporphyrins in biomedicine and diagnostic magnetic resonance imaging | |
Ni et al. | Aggregation-induced generation of reactive oxygen species: mechanism and photosensitizer construction | |
Montaseri et al. | Recent advances in porphyrin-based inorganic nanoparticles for cancer treatment | |
Chedid et al. | Recent trends in covalent and metal organic frameworks for biomedical applications | |
Plekhova et al. | Development of novel tetrapyrrole structure photosensitizers for cancer photodynamic therapy | |
Lin et al. | Improving the phototherapeutic efficiencies of molecular and nanoscale materials by targeting mitochondria | |
Liew et al. | Recent emergence of rhenium (I) tricarbonyl complexes as photosensitisers for cancer therapy | |
Mehraban et al. | Developments in PDT sensitizers for increased selectivity and singlet oxygen production | |
Yu et al. | AIE-active photosensitizers: manipulation of reactive oxygen species generation and applications in photodynamic therapy | |
Yue et al. | Melanin-like nanomedicine in photothermal therapy applications | |
Choi et al. | Enhanced photodynamic anticancer activities of multifunctional magnetic nanoparticles (Fe3O4) conjugated with chlorin e6 and folic acid in prostate and breast cancer cells | |
Kustov et al. | Solvation, cancer cell photoinactivation and the interaction of chlorin photosensitizers with a potential passive carrier non-ionic surfactant Tween 80 | |
Jenni et al. | Molecular theranostic agents for photodynamic therapy (PDT) and magnetic resonance imaging (MRI) | |
Gjuroski et al. | Probing the interactions of porphyrins with macromolecules using NMR spectroscopy techniques | |
Pobłocki et al. | Coordination complexes as a new generation photosensitizer for photodynamic anticancer therapy | |
Vega et al. | Redox-responsive porphyrin-based polysilsesquioxane nanoparticles for photodynamic therapy of cancer cells | |
Qi et al. | Recent development of rhenium-based materials in the application of diagnosis and tumor therapy | |
Dandash et al. | Porphyrin/chlorin derivatives as promising molecules for therapy of colorectal cancer | |
Pérez et al. | Porphyrin–Schiff base conjugates bearing basic amino groups as antimicrobial phototherapeutic agents | |
Tan et al. | NIR-II aggregation-induced emission luminogens for tumor phototheranostics | |
Lai et al. | Biodegradable metal organic frameworks for multimodal imaging and targeting theranostics | |
Zhao et al. | 880 nm NIR-triggered organic small molecular-based nanoparticles for photothermal therapy of tumor | |
Marko et al. | Targeted nanoparticles for fluorescence imaging of folate receptor positive tumors | |
Figueira et al. | Porphyrin nanometal-organic frameworks as cancer theranostic agents | |
Luo et al. | Smart biomimetic nanozymes for precise molecular imaging: application and challenges |